手紙: E.M.I. によるスキャンと頭部損傷のスキャン

Correlates and characteristics of hepatitis C virus-specific T-cell immunity in exposed uninfected high-risk prison inmates.

Journal of viral hepatitis·2013

Detection of herpes viruses in the cerebrospinal fluid of adults with suspected viral meningitis in Malawi.

Infection·2012

Phase I dose-escalation study to determine the safety, pharmacokinetics and pharmacodynamics of brivanib alaninate in combination with full-dose cetuximab in patients with advanced gastrointestinal malignancies who have failed prior therapy.

British journal of cancer·2011

Death after head injury: the 13 year outcome of a case control study.

Journal of neurology, neurosurgery, and psychiatry·2011

A phase I study to determine the safety, pharmacokinetics and pharmacodynamics of a dual VEGFR and FGFR inhibitor, brivanib, in patients with advanced or metastatic solid tumors.

Annals of oncology : official journal of the European Society for Medical Oncology·2010

Quality in healthcare and the quest for improvement.

Scottish medical journal·2008

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Dual-scale and dual-channel oblique plane microscopy for multi-resolution imaging of large tissue specimens.

Biomedical optics express·2026

Quantitative dynamic full-field optical coherence tomography for high-resolution intraoperative imaging of head and neck squamous cell carcinoma.

Biomedical optics express·2026

Deep learning fusion of multi-channel imaging from polarization-sensitive optical coherence tomography.

Biomedical optics express·2026

Deep progressive learning reconstruction for fast and low-dose whole-body PET scans in an integrated PET/MR system.

BMC medical imaging·2026

Simultaneous single-cell calcium imaging of neuronal population activity and brain-wide BOLD fMRI.

Nature methods·2026

CBCT dose reduction with HyperSight on an Ethos linear accelerator: A phantom-based TLD measurement study.

Zeitschrift fur medizinische Physik·2026

関連する実験動画

手紙: E.M.I. によるスキャンと頭部損傷のスキャン

関連する概念動画

Correlates and characteristics of hepatitis C virus-specific T-cell immunity in exposed uninfected high-risk prison inmates.

Detection of herpes viruses in the cerebrospinal fluid of adults with suspected viral meningitis in Malawi.

Phase I dose-escalation study to determine the safety, pharmacokinetics and pharmacodynamics of brivanib alaninate in combination with full-dose cetuximab in patients with advanced gastrointestinal malignancies who have failed prior therapy.

Death after head injury: the 13 year outcome of a case control study.

A phase I study to determine the safety, pharmacokinetics and pharmacodynamics of a dual VEGFR and FGFR inhibitor, brivanib, in patients with advanced or metastatic solid tumors.

Quality in healthcare and the quest for improvement.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Dual-scale and dual-channel oblique plane microscopy for multi-resolution imaging of large tissue specimens.

Quantitative dynamic full-field optical coherence tomography for high-resolution intraoperative imaging of head and neck squamous cell carcinoma.

Deep learning fusion of multi-channel imaging from polarization-sensitive optical coherence tomography.

Deep progressive learning reconstruction for fast and low-dose whole-body PET scans in an integrated PET/MR system.

Simultaneous single-cell calcium imaging of neuronal population activity and brain-wide BOLD fMRI.

CBCT dose reduction with HyperSight on an Ethos linear accelerator: A phantom-based TLD measurement study.

関連する実験動画

手紙: E.M.I. による スキャンと頭部損傷のスキャン

関連する概念動画

関連記事

手紙: E.M.I. によるスキャンと頭部損傷のスキャン